Can Hydrochlorothiazide (HCTZ) cause hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, hydrochlorothiazide (HCTZ) can cause low sodium levels (hyponatremia) in the blood. HCTZ is a thiazide diuretic commonly prescribed for high blood pressure that works by increasing urine output, which helps reduce blood pressure. According to the study published in the European Heart Journal 1, thiazides like HCTZ can cause hypokalaemia, hypomagnesaemia, and hyponatraemia as major side effects.

Mechanism of Action

The mechanism by which HCTZ leads to hyponatremia involves its action on the kidneys, where it increases sodium excretion, potentially leading to excessive sodium loss. This is supported by the 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults, which states that diuretics can cause the depletion of important cations, including sodium, and predispose patients to serious complications 1.

Risk Factors and Symptoms

This side effect is more common in elderly patients, those taking higher doses, and people who are also on a low-sodium diet or other medications that affect sodium levels. Symptoms of low sodium may include headache, confusion, fatigue, muscle weakness, and in severe cases, seizures or coma. Patients taking HCTZ should be aware of these potential symptoms and report them to their healthcare provider.

Monitoring and Prevention

Regular blood tests to monitor electrolyte levels, including sodium, are often recommended for people taking this medication, especially when starting treatment or adjusting dosage. The use of potassium-sparing diuretics or ACE inhibitors alongside HCTZ can help mitigate the risk of electrolyte depletion, as suggested by the guidelines 1. However, the most recent and highest quality study on this topic, published in 2009, emphasizes the importance of careful monitoring and management of electrolyte levels in patients taking diuretics for heart failure 1.

Conclusion is not allowed, so the answer just ends here.

From the FDA Drug Label

OVERDOSAGE The most common signs and symptoms observed are those caused by electrolyte depletion (hypokalemia, hypochloremia, hyponatremia) and dehydration resulting from excessive diuresis.

  • Hyponatremia (low sodium) is listed as a sign of electrolyte depletion caused by hydrochlorothiazide (HCTZ) overdosage.
  • The drug label directly supports that HCTZ can cause low sodium levels, specifically in the context of overdosage and excessive diuresis. 2

From the Research

HCTZ and Low Sodium Levels

  • HCTZ (hydrochlorothiazide) is a thiazide diuretic that can cause hyponatremia, a condition characterized by low sodium levels in the blood 3.
  • A study published in 2015 reported a case of severe hyponatremia associated with HCTZ use, highlighting the importance of monitoring sodium levels in patients taking this medication 3.
  • Another study found that the addition of low-dose HCTZ to angiotensin II receptor blocker treatment can cause significant reductions in serum sodium levels in elderly Japanese subjects with low salt intake 4.

Mechanism and Risk Factors

  • The exact mechanism of thiazide-induced hyponatremia is unclear, but it is thought to be related to the drug's effect on the kidneys and the regulation of electrolyte balance 3.
  • Low salt intake may increase the risk of hyponatremia in patients taking HCTZ, as seen in a study where subjects with low salt intake (<8.9 g/day) experienced significant reductions in serum sodium levels 4.

Comparison with Other Diuretics

  • Spironolactone, a potassium-sparing diuretic, does not appear to affect serum sodium levels, whereas HCTZ can decrease serum potassium levels and increase serum urate and total cholesterol concentrations 5, 6.
  • A study comparing the effects of HCTZ and spironolactone on metabolic parameters found that spironolactone had a calcium-sparing effect, which may be beneficial for patients with hypertension 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.